Show simple item record

dc.contributor.authorHenao-Restrepo, AM
dc.contributor.authorCamacho, A
dc.contributor.authorLongini, IM
dc.contributor.authorWatson, CH
dc.contributor.authorEdmunds, WJ
dc.contributor.authorEgger, M
dc.contributor.authorCarroll, MW
dc.contributor.authorDean, NE
dc.contributor.authorDiatta, I
dc.contributor.authorDoumbia, M
dc.contributor.authorDraguez, B
dc.contributor.authorDuraffour, S
dc.contributor.authorEnwere, G
dc.contributor.authorGrais, RF
dc.contributor.authorGunther, S
dc.contributor.authorGsell, PS
dc.contributor.authorHossmann, S
dc.contributor.authorWatle, SV
dc.contributor.authorKondé, MK
dc.contributor.authorKéïta, S
dc.contributor.authorKone, S
dc.contributor.authorKuisma, E
dc.contributor.authorLevine, MM
dc.contributor.authorMandal, S
dc.contributor.authorMauget, T
dc.contributor.authorNorheim, G
dc.contributor.authorRiveros, X
dc.contributor.authorSoumah, A
dc.contributor.authorTrelle, S
dc.contributor.authorVicari, AS
dc.contributor.authorRøttingen, JA
dc.contributor.authorKieny, MP
dc.date.accessioned2017-01-12T20:59:38Z
dc.date.available2017-01-12T20:59:38Z
dc.date.issued2016-12-23
dc.date.submitted2017-01-11
dc.identifier.citationEfficacy and Effectiveness of an rVSV-Vectored Vaccine in Preventing Ebola Virus Disease: Final Results from the Guinea Ring Vaccination, Open-Label, Cluster-Randomised Trial (Ebola Ça Suffit!). 2016 Lanceten
dc.identifier.issn1474-547X
dc.identifier.pmid28017403
dc.identifier.doi10.1016/S0140-6736(16)32621-6
dc.identifier.urihttp://hdl.handle.net/10144/618745
dc.description.abstractrVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested the effect of rVSV-ZEBOV in preventing Ebola virus disease in contacts and contacts of contacts of recently confirmed cases in Guinea, west Africa.
dc.language.isoenen
dc.publisherElsevieren
dc.rightsArchived with thanks to Lancet (London, England)en
dc.titleEfficacy and Effectiveness of an rVSV-Vectored Vaccine in Preventing Ebola Virus Disease: Final Results from the Guinea Ring Vaccination, Open-Label, Cluster-Randomised Trial (Ebola Ça Suffit!)en
dc.identifier.journalLancet (London, England)en
refterms.dateFOA2019-03-04T13:04:44Z
html.description.abstractrVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested the effect of rVSV-ZEBOV in preventing Ebola virus disease in contacts and contacts of contacts of recently confirmed cases in Guinea, west Africa.


Files in this item

Thumbnail
Name:
Henao Restrepo AM et al - 2016 ...
Size:
857.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record